Skip to main content
SafeTo
SafeTo
Beta
Food & BeveragePet SafetyDrug InteractionsChemicals
More
SafeTo
Instant, expert-verified safety answers for life's specific moments.
About
Careers
We're Hiring!
Privacy
Terms

© 2026 SafeTo. All rights reserved. Made with care for your safety.
  1. Home
  2. ›
  3. Drug Interactions
  4. ›
  5. Lisinopril (ACE inhibitor) and Bilateral renal artery stenosis

INTERACTION STATUS
Major Interaction / Contraindicated
Lisinopril (ACE inhibitor)
Bilateral renal artery stenosis
Clinical Summary

ACE inhibitors can precipitate acute kidney injury, severe hyperkalemia, and hypotension in patients with bilateral renal artery stenosis due to loss of angiotensin II–mediated efferent arteriolar constriction.

Critical Warnings

ACE inhibitors are contraindicated in untreated bilateral renal artery stenosis.

A rise in creatinine >30% after starting therapy signals unsafe interaction.

Hyperkalemia can develop rapidly; monitor K⁺ closely.

Revascularization may allow safe ACE‑I use, but only after specialist assessment.

Jump to:VerdictAnalysis
Share:
Medical Analysis
Mechanism

In bilateral renal artery stenosis, renal perfusion pressure is already reduced. ACE inhibitors block the conversion of angiotensin I to angiotensin II, eliminating angiotensin II–driven efferent arteriole constriction that maintains glomerular filtration pressure. The resulting drop in glomerular filtration pressure leads to a rapid rise in serum creatinine and possible renal failure. Additionally, reduced aldosterone secretion promotes potassium retention, increasing hyperkalemia risk.

Clinical Impact & Risks
  • Acute rise in serum creatinine (≥30% within 1–2 weeks)
  • Potential for acute renal failure requiring dialysis
  • Marked hyperkalemia (K⁺ >5.5 mmol/L)
  • Exacerbated hypotension, especially in volume‑depleted patients
Management & Recommendations
  1. Avoid initiation of ACE inhibitors in patients with known bilateral renal artery stenosis unless benefits outweigh risks and close monitoring is feasible.
  2. If therapy is already started, discontinue the ACE inhibitor immediately upon a ≥30% rise in creatinine or development of hyperkalemia.
  3. Monitor serum creatinine and potassium within 1–2 weeks of initiation or dose change, then at least monthly.
  4. Consider alternative antihypertensives that do not affect the renin‑angiotensin system (e.g., calcium‑channel blockers, beta‑blockers) or revascularization of the stenotic arteries if indicated.
  5. Educate patients to report symptoms of dizziness, reduced urine output, or swelling.

Was this helpful?

0
0
⚠️ Disclaimer

The content on SafeTo is for informational purposes only and does not constitute medical, veterinary, or professional advice. Always consult with a qualified professional for specific concerns.

Related Interactions

Other interactions you might want to check

drug-interaction
Caution
MAOIs and Hot Chocolate

Hot chocolate contains small amounts of tyramine and phenylethylamine, which can interact with MAOIs, potentially leading to a hypertensive crisis if consumed in large quantities, though the risk is generally low with moderate intake.

Learn more
drug-interaction
Caution
Warfarin and Kale

Kale, a vitamin K-rich leafy green, can interact with warfarin by potentially reducing its anticoagulant effects if intake is inconsistent or excessive.

Learn more
drug-interaction
Caution
Statins and Lime Juice

Large amounts of lime juice may mildly interact with certain statins, similar to but less potent than grapefruit juice, by inhibiting drug metabolism and potentially increasing statin levels in the blood.

Learn more